The Hippo pathway effector YAP controls mouse hepatic stellate cell activation

Role of YAP/TAZ in mechanotransduction

Dupont, S., Morsut, L., Aragona, M., Enzo, E., Giulitti, S., Cordenonsi, M., Zanconato, F., Le Digabel, J., Forcato, M., Bicciato, S., et al. (2011) · Nature · doi:10.1038/nature10137 · Cited by 5,979

Taking Cell-Matrix Adhesions to the Third Dimension

Cukierman, E., Pankov, R., Stevens, D. R., & Yamada, K. M. (2001) · Science · doi:10.1126/science.1064829 · Cited by 3,027

Hepatic Stellate Cells: Protean, Multifunctional, and Enigmatic Cells of the Liver

Friedman, S. L. (2008) · Physiological Reviews · doi:10.1152/physrev.00013.2007 · Cited by 2,842

Elucidation of a universal size-control mechanism in Drosophila and mammals

Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., & Pan, D. (2007) · Cell · doi:10.1016/j.cell.2007.07.019 · Cited by 2,370

Genetic and pharmacological disruption of the TEAD–YAP complex suppresses the oncogenic activity of YAP

Liu-Chittenden, Y., Huang, B., Shim, J. S., Chen, Q., Lee, S.-J., Anders, R. A., Liu, J. O., & Pan, D. (2012) · Genes & Development · doi:10.1101/gad.192856.112 · Cited by 1,452

Fate tracing reveals hepatic stellate cells as dominant contributors to liver fibrosis independent of its aetiology

Mederacke, I., Hsu, C. C., Troeger, J. S., Huebener, P., Mu, X., Dapito, D. H., Pradere, J.-P., & Schwabe, R. F. (2013) · Nature Communications · doi:10.1038/ncomms3823 · Cited by 1,443

YAP1 increases organ size and expands undifferentiated progenitor cells

Camargo, F. D., Gokhale, S., Johnnidis, J. B., Fu, D., Bell, G. W., Jaenisch, R., & Brummelkamp, T. R. (2007) · Current Biology · doi:10.1016/j.cub.2007.10.039 · Cited by 1,252

The emerging roles of YAP and TAZ in cancer

Moroishi, T., Hansen, C. G., & Guan, K. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3876 · Cited by 1,181

Hippo signaling: growth control and beyond

Halder, G. A., & Johnson, R. L. (2010) · Development · doi:10.1242/dev.045500 · Cited by 1,091

Mst1 and Mst2 Maintain Hepatocyte Quiescence and Suppress Hepatocellular Carcinoma Development through Inactivation of the Yap1 Oncogene

Zhou, D., Conrad, C. H., Xia, F., Park, J.-S., Payer, B., Yin, Y., Lauwers, G. Y., Thasler, W. E., Lee, J. T., Avruch, J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.09.026 · Cited by 937

High dose methylprednisolone mediates YAP/TAZ-TEAD in vocal fold fibroblasts with macrophages

Nakamura, R., Bing, R., Gartling, G. J., Garabedian, M. J., & Branski, R. C. (2025) · Scientific Reports · doi:10.1038/s41598-025-95459-z · Cited by 4

CuATSM Enhances Wound Repair Without Scarring via Hippo/ YAP Signalling Pathway to Reduce Ferroptosis and Macrophage Polarisation

Tang, Y., Ye, J., Xu, T., Sun, Y., Meng, W., Zhu, L., Jia, Z., Wu, Q., Chen, D., & Wu, F. (2025) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.70590 · Cited by 5

CD47-mediated regulation of glucose and lipid metabolism: implications for the pathogenesis of MASLD

Jiang, X., Zhao, W., Shen, B., Han, Y., & Chen, K. (2025) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1535382 · Cited by 6

Roles and potential mechanisms of hepatic stellate cells activation mediated by epigenetics through insulin like growth factor 1 and receptor: A review

Chen, S., Gao, J., Chen, J., Huang, Y., Wang, L., Lin, J., Zhao, M., Shen, Y., Zhao, G., & Cheng, Y. (2025) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2025.147642 · Cited by 4

Deciphering the Role of Oroxylin A in Liver Fibrosis

Wang, S., Wu, J., Sun, J., Chen, W., Tian, Z., Huang, S., & Wang, M. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s530387 · Cited by 4

FNDC4 regulates TGF-β1-induced hepatic stellate cell activation and liver fibrosis via the AMPK/YAP pathway

Neira, G., Montiel‐Duarte, C., Becerril, S., Valentí, V., Moncada, R., Catalán, V., Gómez‐Ambrosi, J., Mugueta, C., Silva, C., Frühbeck, G., et al. (2026) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2026.03.017 · Cited by 4

Evaluation of Verteporfin as a Novel Antifibrotic Agent in a Rabbit Model of Glaucoma Filtration Surgery

Sun, M. T., Cotton, R. M., Charoenkijkajorn, C., Garcia-Sanchez, J., Dalal, R., Xia, X., Lin, J. H., Singh, K., Goldberg, J. L., & Liu, W. W. (2023) · Ophthalmology Science · doi:10.1016/j.xops.2023.100448 · Cited by 4

ER stress-induced YAP upregulation leads to chondrocyte phenotype loss in age-related osteoarthritis

Gao, Y., Wei, H., Peng, X., Wang, C., Zhu, H., & Yin, J. (2024) · Frontiers in Pharmacology · doi:10.3389/fphar.2024.1476255 · Cited by 4

Baricitinib Mitigates Methotrexate-Induced Liver Fibrosis Model via YAP Pathway

Ulusan, M., Erdoğan, M. A., ŞİMŞEK, Ö., Dogan, Z., Ciftci, B. B., Atalan, G., & Erbaş, O. (2025) · Medicina · doi:10.3390/medicina61050857 · Cited by 4

Shaoyao Gancao decoction promotes splenic immune homeostasis mediating cGAS-STING signaling pathway to delay autoimmune hepatitis progression

Xu, A., Zhang, Z., Zhu, B., Xiao, M., Jiang, X., Yang, Y., & Zhao, M. (2025) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2025.120121 · Cited by 4

Traditional Chinese medicine Yiqi Huoxue recipe attenuates hepatic fibrosis via YAP/TAZ signaling.

Zhao, W. T., Zhang, X., Hou, M., Zhang, Y., Tang, Y., Li, L., Dong, S., Liu, L., Zhao, D., Li, W., et al. (2021) · PubMed · doi:10.14670/hh-18-373 · Cited by 4

Optimization of physical microenvironment to maintain the quiescence of human induced pluripotent stem cell‐derived hepatic stellate cells

Gong, Y., Danoy, M., Kido, T., Mitsuhashi, K., Choi, H.-J., Matsugi, T., Yang, J., Esashika, K., TAKAHASHI, J. C., Nishikawa, M., et al. (2023) · Biotechnology and Bioengineering · doi:10.1002/bit.28485 · Cited by 4

Assessment and management of portal hypertension in patients with MASLD: advances and caveats

Rojo, D., Jiménez-Masip, A., Pagès, L., Bañares, J., Sabiote, C., Martínez-Gómez, M., Aceituno, L., Cusidó, M. S., Salcedo-Allende, M. T., Calixto, Z., et al. (2025) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2025.2530605 · Cited by 3

Unravelling the reversion mechanisms of activated hepatic stellate cell properties by extracellular vesicles from mesenchymal stem cells

Islam, M. A., Mawya, J., Salma, U., Kasim, N. H. A., & Haque, N. (2025) · World Journal of Stem Cells · doi:10.4252/wjsc.v17.i11.111090 · Cited by 3

An organotypic model of ductular reaction reveals a mevalonate-dependent vulnerability in reactive biliary cells

Anfuso, B., Velnati, S., Selvestrel, D., Garlant, C., Ferracci, E., Baj, G., Parisse, P., Overi, D., Bertolio, R., Bulla, R., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.116681 · Cited by 3

Dihydroartemisinin: A Promising Therapeutic Agent Against the Hepatitis-to-Hepatocellular Carcinoma Cascade

Wang, T., Jiang, W., Li, J., Ma, J., Zhang, Y., Zheng, J., Chen, J., Wen, Y., Ma, X., & Zeng, J. (2025) · Drug Design Development and Therapy · doi:10.2147/dddt.s554484 · Cited by 4

Synergistic therapeutic strategies for metabolic dysfunction-associated steatohepatitis and type 2 diabetes mellitus: molecular insights and clinical advances

Zhu, B. J. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2025.1753393 · Cited by 3

Liver Fibrosis: Molecular Pathogenesis and Therapeutic Interventions

Qu, J., Qin, W., Dong, M., Ma, Z., Li, S., Liu, R., Chen, R., Li, C. H., & Li, X. (2026) · MedComm · doi:10.1002/mco2.70750 · Cited by 3

Mechanisms and reversal strategies of liver fibrosis: from regulation of cell fate to clinical translation

Zeng, C., Lu, Q., Zhao, Q., & Li, J. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08312-w · Cited by 3

Transient receptor potential channel 6 knockout ameliorates hepatic fibrosis by inhibiting the activation and proliferation of hepatic stellate cells

Zeng, X., Liao, Y., & Cheng, W. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16802 · Cited by 3

Plasticity of adult hepatocytes and readjustment of cell fate: a novel dogma in liver disease

Cubero, F. J., & Martínez‐Chantar, M. L. (2019) · Gut · doi:10.1136/gutjnl-2019-318218 · Cited by 3

Structure, Function and Responses to Injury

Crawford, J. M., Bioulac‐Sage, P., & Hytiroglou, P. (2023) · Elsevier eBooks · doi:10.1016/b978-0-7020-8228-3.00001-6 · Cited by 3

Yes-associated protein inhibition ameliorates carbon tetrachloride-induced acute liver injury in mice by reducing VDR

Wang, P., Pan, J., Gong, S., Zhang, Z., & Li, B. (2024) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2024.111139 · Cited by 3

Relation between immunohistochemical expression of hippo pathway effectors and chronic hepatitis induced fibrosis in egyptian patients

Abdallah, R. A., Shaban, M. I., Taie, D. M., Asaad, N. Y., & Badr, A. (2019) · Turkish Journal of Pathology · doi:10.5146/tjpath.2019.01463 · Cited by 3

Liver Structural Injury in Leptin-Deficient (ob/ob) Mice: Lipogenesis, Fibrogenesis, Inflammation, and Apoptosis

Martins, F. F., Souza‐Mello, V., de Carvalho, J. J., del Sol, M., Águila, M. B., & Mandarim‐de‐Lacerda, C. A. (2021) · International Journal of Morphology · doi:10.4067/s0717-95022021000300732 · Cited by 3

The influence of tissue spatial geometry and functional organisation on liver regeneration

Aloia, L. (2021) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2021.09.011 · Cited by 4

[YAP1 knockdown suppresses the proliferation, migration and invasion of human nasopharyngeal carcinoma cells].

Zhou, Y., Yang, R., & Ma, G. (2019) · Europe PMC (PubMed Central) · doi:10.12122/j.issn.1673-4254.2019.03.05 · Cited by 3

Role of integrin α4 in the inhibition of fibrosis in activated hepatic stellate cells by Periplaneta americana extract

Fang, Y., Liu, Y., Li, D., Miu, Y., Chen, K., Zhou, J., Xie, L., Chen, X., Wu, J., Zhu, Y., et al. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1517491 · Cited by 2

Levodopa and the dopamine receptor D1-Hippo/yes-associated protein axis: A novel therapeutic avenue for liver fibrosis

Xie, S.-S., & Liu, Z.-G. (2025) · World Journal of Gastroenterology · doi:10.3748/wjg.v31.i46.113298 · Cited by 2

Osteopontin aggravates myocardial fibrosis by promoting phenotypic transition of cardiac fibroblasts via Hippo-YAP pathway

Liu, C., Liu, W., Wang, Y., Jiang, C., Chen, S., Huang, Q., Xiong, X., Wang, L., Zeng, G., & Huang, Q. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.168150 · Cited by 2

La plasticidad del hepatocito y su relevancia en la fisiología y la patología hepática

Ríos-López, D. G., Aranda-López, Y., Sosa‐Garrocho, M., & Macías‐Silva, M. (2020) · TIP Revista Especializada en Ciencias Químico-Biológicas · doi:10.22201/fesz.23958723e.2020.0.225 · Cited by 4

Anti-fibrogenic effect of umbilical cord–derived mesenchymal stem cell–conditioned media in human esophageal fibroblasts

Choi, Y. J., Kim, J. H., Lee, Y., Pyeon, H., Yoo, I. K., & Yoo, J. H. (2024) · Scientific Reports · doi:10.1038/s41598-024-73091-7 · Cited by 2

Mechanical mechanics-reclaiming a new battlefield for chronic liver disease

Zhang, Y., Ma, T., Lu, X., Hua, H., Wu, L., & Chen, Z. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.05.028 · Cited by 3

Deficiency of vitamin D-binding protein exacerbates liver fibrosis by disrupting iron homeostasis via the activation of YAP signaling

Zheng, Q., Tan, Q., Wang, D., Ma, Y., Zhou, Y., Chen, Y., Long, D., Yang, J., & Li, F. (2025) · Experimental Cell Research · doi:10.1016/j.yexcr.2025.114767 · Cited by 2

DAMP-Promoted Efferent Innate Immune Responses in Human Diseases: Fibrosis

Land, W. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-53868-2_6 · Cited by 2

Plasma Yap1 Predicts Esophageal Varices and The Risk of Variceal Bleeding in Liver Cirrhosis

Zhao, W. T., Xue, N., Cui, P., Liu, L., Wang, Y., Zhang, X., Tang, Y., Du, H., & Nan, Y. (2021) · Biomarkers in Medicine · doi:10.2217/bmm-2020-0573 · Cited by 2

Generation and Culture of Primary Mouse Hepatocyte–Hepatic Stellate Cell Spheroids

Mannaerts, I., Eysackers, N., & van Grunsven, L. A. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-3207-9_11 · Cited by 2

Liver X Receptor β Controls Hepatic Stellate Cell Activation via Hedgehog SignalingPreprint

Zhong, L., Huang, S., Du, X., Cai, C., Zhou, Y., Shen, W., Deng, L., & Ning, B. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/577833 · Cited by 2

YAP nuclear translocation through dynein and acetylated microtubule controls fibroblast activationPreprint

You, E., Ko, P., Jeong, J., Keum, S., Kim, J.-W., Seo, Y., Song, W. K., & Rhee, S. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/693168 · Cited by 2

Deciphering cell-fiber interactions through using reduced electrospun fiber density

Gao, X. Y., Wang, L., Jia, W., Jiang, F., Zheng, Q., Wang, X., Liu, Y., Wen, M., & An, M. (2025) · European Polymer Journal · doi:10.1016/j.eurpolymj.2025.114191 · Cited by 1

Rigidity Sensing of Inclusions Directs Differentiated Cell Elongation and Force Generation across Phenotypes

Luo, Y., & Luo, Y. (2025) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.5c01611 · Cited by 1

Alamandine Attenuates Hypoxia-Induced Atrial Fibrosis and Atrial Fibrillation by Involving the YAP/TAZ Pathway

Yang, W., Yang, L., Zhou, M., Liu, T., Chen, K., Wang, X., & Liu, C. (2025) · Cardiovascular Drugs and Therapy · doi:10.1007/s10557-025-07819-6 · Cited by 1

New combination therapy of praziquantel and Lactobacillus plantarum for enhancing the treatment of clonorchiasis in mice

Ma, Y., Wang, X., Zhang, X., Yu, Y., Liu, Z., Bao, P., Liu, M., Wang, Y., Yuan, X., Wang, H., et al. (2026) · Food and Waterborne Parasitology · doi:10.1016/j.fawpar.2026.e00333 · Cited by 1

Hippo signalling in cellular and tissue-level metabolism across health and disease

Bigot, S., Bahrami, A., & Ardestani, A. D. (2026) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2026.05.002 · Cited by 1

Actin cytoskeletal dynamics in hepatic myofibroblasts and fibrosis

Shi, Z., & Rockey, D. C. (2026) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-026-01223-7 · Cited by 2

The circadian clock controls hepatic stellate cell activation via a BMAL1/CK1ε/REV-ERBα/transgelin signaling pathway

Johanns, M., Berthier, A., Vandel, J., Courquet, S., Lapage, M., Dubois‐Chevalier, J., Vinod, M., Very, N., Zummo, F. P., Bobowski, M., et al. (2026) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2611767123 · Cited by 2

Therapeutic Mechanisms of Resmetirom and Semaglutide in MASLD/MASH: A Review of Inflammatory and Fibrotic Metabolites

Toshikuni, N. (2026) · Metabolites · doi:10.3390/metabo16080586 · Cited by 1

MicroRNA Control of Hepatocyte–Stromal Crosstalk in the Early Premalignant Microenvironment of HBV-Associated HCC

Sartorius, K., Kramvis, A., & Chuturgoon, A. A. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177581 · Cited by 1

Liver Fibrosis: Current Approaches and Future Directions for Diagnosis and Treatment

Chen, J. Y., Thakar, D., & Chang, T. T. (2018) · Molecular and translational medicine · doi:10.1007/978-3-319-98143-7_15 · Cited by 2

Liver cancer: the tumor microenvironment and associated pathways

Banik, A., Shaw, K., Dar, A. A., Peela, S., & Kancharla, P. K. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-98807-0.00022-3 · Cited by 1

The logic of size regulation: the Hippo pathway in organ size control

Zhong, Z., & Yu, F. (2025) · Chinese Science Bulletin (Chinese Version) · doi:10.1360/tb-2024-1373 · Cited by 1

Ginsenoside Rb1-based dual-functional liposomes for enhanced siRNA delivery and synergistic anti-fibrotic therapy of hepatic fibrosis

Li, J., Li, S., He, D., Hu, Y., Tian, Z., Wang, Y., Ling, X., He, Z., Li, M., & He, Q. (2025) · Nano Research · doi:10.26599/nr.2025.94908113 · Cited by 1

Fibrotic Signaling in Cardiomyopathies

Ravi, S., Willis, M. S., & Schisler, J. C. (2018) · Molecular and translational medicine · doi:10.1007/978-3-319-98143-7_10 · Cited by 1

Liver Mechanics and the Profibrotic Response at the Cellular Level

Wells, R. G. (2020) · Springer eBooks · doi:10.1007/978-3-030-40542-7_56 · Cited by 1

Maternal Western-style Diet Promotes Immune Tolerance and Liver Sinusoidal Endothelial Cell Dysfunction in Nonhuman Primate Juvenile Offspring LiverPreprint

Nash, M. J., Nelson, B. N., McGuckin, M. M., Janssen, R. C., Jones, K. L., Al‐Juboori, S. I., Dobrinskikh, E., Kievit, P., Aagaard, K. M., McCurdy, C. E., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.01.06.697995 · Cited by 1

Matrix stiffness may drive multi-cellular crosstalk via YAP signaling in biliary atresia liver fibrosis: a mechanistic review

Cheng, J. (2026) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2026.1842681

Mechanical stiffness orchestrates distinct regulation of MRTFs and YAP / TAZ transcriptional cofactors in hepatocytes

Torres‐Ortiz, B. S., Pérez‐Calixto, D., Carretero‐Ortega, J., Guzman‐López, A. G., Pinto‐Dueñas, D. C., Hernández‐Juárez, M., Jiménez‐Escobar, A., Rodríguez‐Hernández, A., Díaz‐Bello, B., Serna‐Márquez, N., et al. (2026) · The FEBS Journal · doi:10.1111/febs.70570

Suberoylanilide hydroxamic acid inhibits LX2 cells proliferation via decreasing yes-associated protein/transcriptional coactivator with PDZ-binding motif proteins

Özel, M., Güçlü, K., Helvacı, N., Kılıç, E., Başkol, M., & Başkol, G. (2020) · Turkish Journal of Biochemistry · doi:10.1515/tjb-2019-0397

Extracellular matrix stiffness regulates degradation of the Hippo kinase MST2 via SCF βTrCPPreprint

Fiore, A. P. Z. P., da Silva, A. M. R., Filho, H. V. R., Manucci, A. C., Ribeiro, P. D. F., Botelho, M. C. S., de Oliveira, P. S. L., Pagano, M., & Bruni‐Cardoso, A. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.01.31.429078

Fate tracing reveals differences between Reelin + HSCs and Desmin + HSCs in activation, migration, and proliferation activitiesPreprint

Chen, N., Liu, S., Qin, D., Guan, D., Chen, Y., Hou, C., Zheng, S., Wang, L., Chen, X., & Zhang, L. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.02.06.479312

Polyisocyanide Hydrogels With Tunable Nonlinear Elasticity Mediate HCC DevelopmentPreprint

Liu, Z., Yuan, H., Ma, B., Cao, Z., Fu, J., Chen, Y., Xing, C., Niu, X., Li, N., Wang, H., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3950314

Review of roles of RNA-binding proteins on NAFLD and the related pharmaceutical measures

Li, C., Yang, F., Yuan, Z., & Wei, X. (2025) · Biomolecules and Biomedicine · doi:10.17305/bb.2025.12465

PEST-containing nuclear protein in eye health and disease: A review

Hussain, W., Jiang, Z.-L., Liu, Y., Wang, J., Yasoob, T. B., Hussain, S. A., Laila, U. E., Wu, D., Ji, X., & Dang, Y. (2025) · Experimental Eye Research · doi:10.1016/j.exer.2025.110451

C/EBP‐α Promotes Mitochondrial Fission and Inhibits the Activation of Hepatic Stellate Cells via YAP‐Drp1 Pathway

Hou, C., Yan, Y., Su, Y., Wang, M., Yang, J., Liu, X., Zhai, X., Wang, Y., & Liu, X. (2025) · Cell Biology International · doi:10.1002/cbin.70058

Exploration of a Class of Aryl Imidazolyl Ureas As Potent Acid Ceramidase Inhibitors for the Treatment of Fibrotic Diseases

Beresis, R. T., Prathigudupu, V., Cable, C., Yu, A., Adler, M., Ramamoorthi, R., Yeon, S. K., Gordan, J. D., Sharma, S. K., DeGrado, W. F., et al. (2025) · ACS Omega · doi:10.1021/acsomega.5c03734

Alcohol-related hepatitis induces a specific fibrosis profile through YAP activation in myofibroblasts

Wandji, L. C. N., Saleh, M. B., Sobolewski, C., Amrani, M. E., Bray, F., Boleslawski, E., Eeckhoute, J., Devaux, P.-J., Maggiotto, F., Taront, S., et al. (2025) · JHEP Reports · doi:10.1016/j.jhepr.2025.101580

HIF-1α/YAP induces interleukin 1β autocrine in hepatocytes, leading to hepatocytic fibrosis: adaptive fibrosis in nonalcoholic fatty liverPreprint

Zhang, J. G. (2025) · Research Square · doi:10.21203/rs.3.rs-6538340/v1

Ivermectin attenuates Schistosoma japonicum-induced liver fibrosis and is associated with downregulation of YAP signaling

Xuan, M., Zhang, P., Guo, J., Guan, F., Lu, S., & Liu, W. (2025) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2025.1678067

Purinergic-Mediated Calcium Signaling in Quiescent and Activated Hepatic Stellate Cells: Evidence That P2Y1 Receptor Delays Activation

Martínez, E. M., Juárez‐Mercado, A. P., González‐Gallardo, A., Núñez-Ríos, J. D., Díaz‐Muñoz, M., Hernández-Muñoz, R. E., & Vázquez‐Cuevas, F. G. (2025) · Cells · doi:10.3390/cells14231845

Additional file 3 of Epstein-Barr viral product-containing exosomes promote fibrosis and nasopharyngeal carcinoma progression through activation of YAP1/FAPα signaling in fibroblasts

Lee, P.-J., Sui, Y.-H., Liu, T.-T., Tsang, N.-M., Huang, C.-H., Lin, T.-Y., Chang, K.-P., & Liu, S.-C. (2022) · Figshare · doi:10.6084/m9.figshare.20521703

Additional file 5 of Epstein-Barr viral product-containing exosomes promote fibrosis and nasopharyngeal carcinoma progression through activation of YAP1/FAPα signaling in fibroblasts

Lee, P.-J., Sui, Y.-H., Liu, T.-T., Tsang, N.-M., Huang, C.-H., Lin, T.-Y., Chang, K.-P., & Liu, S.-C. (2022) · Figshare · doi:10.6084/m9.figshare.20521709

Additional file 1 of Epstein-Barr viral product-containing exosomes promote fibrosis and nasopharyngeal carcinoma progression through activation of YAP1/FAPα signaling in fibroblasts

Lee, P.-J., Sui, Y.-H., Liu, T.-T., Tsang, N.-M., Huang, C.-H., Lin, T.-Y., Chang, K.-P., & Liu, S.-C. (2022) · Figshare · doi:10.6084/m9.figshare.20521697

Additional file 10 of Epstein-Barr viral product-containing exosomes promote fibrosis and nasopharyngeal carcinoma progression through activation of YAP1/FAPα signaling in fibroblasts

Lee, P.-J., Sui, Y.-H., Liu, T.-T., Tsang, N.-M., Huang, C.-H., Lin, T.-Y., Chang, K.-P., & Liu, S.-C. (2022) · Figshare · doi:10.6084/m9.figshare.20521691

Additional file 8 of Epstein-Barr viral product-containing exosomes promote fibrosis and nasopharyngeal carcinoma progression through activation of YAP1/FAPα signaling in fibroblasts

Lee, P.-J., Sui, Y.-H., Liu, T.-T., Tsang, N.-M., Huang, C.-H., Lin, T.-Y., Chang, K.-P., & Liu, S.-C. (2022) · Figshare · doi:10.6084/m9.figshare.20521718

Additional file 11 of Epstein-Barr viral product-containing exosomes promote fibrosis and nasopharyngeal carcinoma progression through activation of YAP1/FAPα signaling in fibroblasts

Lee, P.-J., Sui, Y.-H., Liu, T.-T., Tsang, N.-M., Huang, C.-H., Lin, T.-Y., Chang, K.-P., & Liu, S.-C. (2022) · Figshare · doi:10.6084/m9.figshare.20521694

Additional file 2 of Epstein-Barr viral product-containing exosomes promote fibrosis and nasopharyngeal carcinoma progression through activation of YAP1/FAPα signaling in fibroblasts

Lee, P.-J., Sui, Y.-H., Liu, T.-T., Tsang, N.-M., Huang, C.-H., Lin, T.-Y., Chang, K.-P., & Liu, S.-C. (2022) · Figshare · doi:10.6084/m9.figshare.20521700

Additional file 9 of Epstein-Barr viral product-containing exosomes promote fibrosis and nasopharyngeal carcinoma progression through activation of YAP1/FAPα signaling in fibroblasts

Lee, P.-J., Sui, Y.-H., Liu, T.-T., Tsang, N.-M., Huang, C.-H., Lin, T.-Y., Chang, K.-P., & Liu, S.-C. (2022) · Figshare · doi:10.6084/m9.figshare.20521721

Additional file 2 of The effects of TGF-β-induced activation and starvation of vitamin A and palmitic acid on human stem cell-derived hepatic stellate cells

Wilhelmsen, I., Combriat, T. M. D., Dalmao‐Fernández, A., Stokowiec, J., Wang, C., Olsen, P. A., Wik, J. A., Boichuk, Y., Aizenshtadt, A., & Krauss, S. J. K. (2024) · Figshare · doi:10.6084/m9.figshare.26361065

Additional file 1 of The effects of TGF-β-induced activation and starvation of vitamin A and palmitic acid on human stem cell-derived hepatic stellate cells

Wilhelmsen, I., Combriat, T. M. D., Dalmao‐Fernández, A., Stokowiec, J., Wang, C., Olsen, P. A., Wik, J. A., Boichuk, Y., Aizenshtadt, A., & Krauss, S. J. K. (2024) · Figshare · doi:10.6084/m9.figshare.26360951

Additional file 4 of Epstein-Barr viral product-containing exosomes promote fibrosis and nasopharyngeal carcinoma progression through activation of YAP1/FAPα signaling in fibroblasts

Lee, P.-J., Sui, Y.-H., Liu, T.-T., Tsang, N.-M., Huang, C.-H., Lin, T.-Y., Chang, K.-P., & Liu, S.-C. (2022) · Figshare · doi:10.6084/m9.figshare.20521706

Additional file 7 of Epstein-Barr viral product-containing exosomes promote fibrosis and nasopharyngeal carcinoma progression through activation of YAP1/FAPα signaling in fibroblasts

Lee, P.-J., Sui, Y.-H., Liu, T.-T., Tsang, N.-M., Huang, C.-H., Lin, T.-Y., Chang, K.-P., & Liu, S.-C. (2022) · Figshare · doi:10.6084/m9.figshare.20521715

Additional file 6 of Epstein-Barr viral product-containing exosomes promote fibrosis and nasopharyngeal carcinoma progression through activation of YAP1/FAPα signaling in fibroblasts

Lee, P.-J., Sui, Y.-H., Liu, T.-T., Tsang, N.-M., Huang, C.-H., Lin, T.-Y., Chang, K.-P., & Liu, S.-C. (2022) · Figshare · doi:10.6084/m9.figshare.20521712

Additional file 3 of The effects of TGF-β-induced activation and starvation of vitamin A and palmitic acid on human stem cell-derived hepatic stellate cells

Wilhelmsen, I., Combriat, T. M. D., Dalmao‐Fernández, A., Stokowiec, J., Wang, C., Olsen, P. A., Wik, J. A., Boichuk, Y., Aizenshtadt, A., & Krauss, S. J. K. (2024) · Figshare · doi:10.6084/m9.figshare.26752888

From HBV to MASLD Cirrhosis: Mechanistic Insights and Therapeutic Strategies

Yu, H., Ding, H., Huang, Y., Cao, H., Ding, Y., & Wang, W. (2026) · Portal hypertension & cirrhosis · doi:10.1002/poh2.70036 · Cited by 1

Transcriptional co-activators YAP/TAZ in cancer-associated fibroblasts are dispensable for Notch-driven intrahepatic cholangiocarcinoma

Deng, T., Qiao, Y., Xie, X., Wu, Y., & Ge, G. (2026) · Journal of Molecular Cell Biology · doi:10.1093/jmcb/mjag010

Molecular thermodynamic aspects of dissipative structures in oncology, inflammatory and degenerative processes of Central Nervous System diseases

Vallée, A. (2017) · theses.fr (ABES) · doi:10.70675/e07edff7z4f56z4165z8ee2z475c4aafb600

Altérations du microenvironnement hépatocytaire suite à l'infection par le virus de l'hépatite C : implication dans la fibrogenèse hépatique précoce

Reungoat, E. (2018) · theses.fr (ABES) · doi:10.70675/2063fa0cz5dbfz4a9fz8600z3fe6db0079a6

Définir de nouvelles cibles thérapeutiques pour l´hépatite alcoolique : nécessité d´une approche translationnelle

Bousaleh, M. (2019) · theses.fr (ABES) · doi:10.70675/d39b3d1bzaa47z40c1zbde5z90e63b846fc9

Identification of portal mesenchymal stem cells and derived myofibroblasts in liver fibrosis

Lei, L. (2020) · theses.fr (ABES) · doi:10.70675/3f63c15ezc769z48acz89d2z46ba95102826

Role of the protein ADAMTS12 in the progression of Chronic Liver Diseases

Azar, F. (2021) · theses.fr (ABES) · doi:10.70675/df5a3af0ze005z4d00z982fz020900d13f4e

La nécroptose : une nouvelle cible thérapeutique dans la stéatohépatite non-alcoolique

Majdi, A. (2020) · theses.fr (ABES) · doi:10.70675/94f28bbaz6c2dz4b48zb1aaze6b48ca72708

Caractérisation de la fibrose dans l'hépatite alcoolique et décryptage des mécanismes liant cette fibrose au défaut du compartiment hépatocytaire

Wandji, L. C. N. (2024) · theses.fr (ABES) · doi:10.70675/d92929e1z2799z4fe2zaf7bzedc978f2f177

GSEA and the coexpression network approach identify novel pathway connections of molecular processes affected in Porto-sinusoidal vascular disease

Iyer, A., Doornbos, C., Evelo, C. T., Kutmon, M., & Ehrhart, F. (2026) · PLoS ONE · doi:10.1371/journal.pone.0347338

From the brain to the liver: A pharmacokinetic dilemma and safety barriers in levodopa-based antifibrotic therapy

Yin, D.-Y., Liu, X.-Y., Li, A., & Ren, Z.-G. (2026) · World Journal of Gastroenterology · doi:10.3748/wjg.117873

Shared mechanisms of organ fibrosis

Humphreys, B. D. (2026) · JCI Insight · doi:10.1172/jci.insight.200952

Characterization of the ctgf Promoter from Nibea coibor and its Response to TGF-β1 During Collagen Synthesis in Swim Bladder Cells

Zou, A., Yuan, Y., Zhu, L., Zhang, Y., Xiao, L., Wen, X., & Lin, F. (2026) · Marine Biotechnology · doi:10.1007/s10126-026-10657-8

Microtubule‐Targeting Drugs Induce Mesenchymal–Epithelial Transition in Hepatic Stellate Cells

Urushima, H., Matsubara, T., Yuasa, H., Daikoku, A., Qiongya, G., Nakai, H., Kadono, C., & Ikeda, K. (2026) · Liver International · doi:10.1111/liv.70780

Linking EMT Dynamics to Cellular Plasticity: YAP/TAZ as Central Regulators Across Physiological and Pathological States

Amicone, L., Cicchini, C., Petti, F., & Marchetti, A. (2026) · Genes · doi:10.3390/genes17080851

Identification of the miR-210-3p–EFNA3–YAP axis and its targeted modulation via biomimetic supramolecular nanoparticles to promote ischemic flap survival

Xu, J., Zhuang, X., Wu, Z. B., Yan, F., Shi, D., Ye, F., Ding, R., Gao, Q., Yao, Q., Liu, Y., et al. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04833-0

p21-activated kinase 4 drives hepatic stellate cell activation and liver fibrosis through the phosphorylation of YAP at T428

Kim, G.-H., Rho, H., Lee, C. H., Hong, Y.-J., Park, Y. R., Yu, H. C., Song, M.-Y., Jo, H. J., Kang, E. J., Han, R., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02796-0

Blockade of YAP alleviates hepatic fibrosis through accelerating apoptosis and reversion of activated hepatic stellate cells

Yu, H., Yao, Y., Bu, F., Chen, Y., Wu, Y., Yang, Y., Chen, X., Zhu, Y., Wang, Q., Pan, X., et al. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.01.004 · Cited by 92

P0444 : The hippo pathway effector YAP controls mouse hepatic stellate cell activation

Mannaerts, I., Leite, S. B., Verhulst, S., Thoen, L. F. R., Claerhout, S., Halder, G. A., & van Grunsven, L. A. (2015) · Journal of Hepatology · doi:10.1016/s0168-8278(15)30653-x · Cited by 2

Hepatocyte Stress Increases Expression of Yes‐Associated Protein and Transcriptional Coactivator With PDZ‐Binding Motif in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis

Mooring, M., Fowl, B. H., Lum, S. Z. C., Liu, Y., Yao, K., Softic, S., Kirchner, R., Bernstein, A., Singhi, A. D., Jay, D. G., et al. (2020) · Hepatology · doi:10.1002/hep.30928 · Cited by 162

p21-activated kinase 4 drives hepatic stellate cell activation and liver fibrosis through the phosphorylation of YAP at T428

Kim, G.-H., Rho, H., Lee, C. H., Hong, Y.-J., Park, Y. R., Yu, H. C., Song, M.-Y., Jo, H. J., Kang, E. J., Han, R., et al. (2026) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-026-02796-0

[YAP/TAZ regulates multiple signal pathways in the genesis and development of hepatic fibrosis].

Pan, H., Liao, M., & Song, P. (2018) · PubMed · doi:10.11817/j.issn.1672-7347.2018.03.013 · Cited by 3